Cargando…
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer
Immunosuppressive molecules are extremely valuable prognostic biomarkers across different cancer types. However, the diversity of different immunosuppressive molecules makes it very difficult to accurately predict clinical outcomes based only on a single immunosuppressive molecule. Here, we establis...
Autores principales: | Wang, Jia-Bin, Li, Ping, Liu, Xiao-Long, Zheng, Qiao-Ling, Ma, Yu-Bin, Zhao, Ya-Jun, Xie, Jian-Wei, Lin, Jian-Xian, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Liu, Li-Chao, Lian, Ning-Zi, Yang, Ying-Hong, Huang, Chang-Ming, Zheng, Chao-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732987/ https://www.ncbi.nlm.nih.gov/pubmed/33311518 http://dx.doi.org/10.1038/s41467-020-20260-7 |
Ejemplares similares
-
Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis
por: Lin, Jian-Xian, et al.
Publicado: (2019) -
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021) -
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Lin, Jian-Xian, et al.
Publicado: (2022) -
Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better?
por: Chen, Qi-Yue, et al.
Publicado: (2020) -
Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019)